Neurocrine Biosciences (NBIX) – Analyst EPS View
-
Neurocrine (NBIX) Earnings Preview: Mizuho Models Sales of $288.2M, Seeks Clarity on Post-COVID Recovery, Reiterates Neutral Rating with $95 Price Target
-
UPDATE: Neurocrine Bio. (NBIX) PT Lowered to $95 at Mizuho Securities
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NBIX Stock Lookup